Investors in Clearside Biomedical from three years ago are still down 63, even after 15 percent gain this past week

CLSD Stock  USD 0.86  0.03  3.37%   
About 63% of all Clearside Biomedical's shareholders are looking to take a long position. The analysis of overall sentiment of trading Clearside Biomedical stock suggests that some investors are interested at this time. The current market sentiment, together with Clearside Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Clearside Biomedical stock news signals to limit their universe of possible portfolio assets.
  
It is a pleasure to report that the Clearside Biomedical, Inc. is up 50 percent in the last quarter. But that...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Clearside Biomedical Current Investor Sentiment

Comfort Level 63

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Clearside Biomedical's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Clearside Biomedical.

Clearside Biomedical Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Clearside Biomedical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Clearside Biomedical Fundamental Analysis

We analyze Clearside Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearside Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearside Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Clearside Biomedical is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Clearside Biomedical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clearside Biomedical stock to make a market-neutral strategy. Peer analysis of Clearside Biomedical could also be used in its relative valuation, which is a method of valuing Clearside Biomedical by comparing valuation metrics with similar companies.

Peers

Clearside Biomedical Related Equities

DRTSAlpha Tau   9.03   
0%
100.0%
SNSESensei Biotherapeutics   6.82   
0%
75.0%
ERASErasca   6.20   
0%
68.0%
INBXInhibrx   5.16   
0%
57.0%
LYRALyra Therapeutics   5.00   
0%
55.0%
CCCCC4 Therapeutics   4.23   
0%
46.0%
DSGNDesign Therapeutics   3.85   
0%
42.0%
OCULOcular Therapeutix   2.88   
0%
31.0%
ORICOric Pharmaceuticals   2.42   
0%
26.0%
KRONKronos Bio   2.08   
0%
23.0%
NXTCNextCure   1.32   
0%
14.0%
GLUEMonte Rosa   0.92   
0%
10.0%
NUVBNuvation Bio   0.51   
5.0%
0%
EWTXEdgewise Therapeutics   0.83   
9.0%
0%
INZYInozyme Pharma   0.83   
9.0%
0%
TNYATenaya Therapeutics   0.99   
10.0%
0%
EPIXESSA Pharma   1.18   
13.0%
0%
EYENEyenovia   1.74   
19.0%
0%
GBIOGeneration Bio   3.57   
39.0%
0%

Complementary Tools for Clearside Stock analysis

When running Clearside Biomedical's price analysis, check to measure Clearside Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearside Biomedical is operating at the current time. Most of Clearside Biomedical's value examination focuses on studying past and present price action to predict the probability of Clearside Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearside Biomedical's price. Additionally, you may evaluate how the addition of Clearside Biomedical to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets